ArticleOncology letters2025
MRI-based diffusion weighted imaging and diffusion kurtosis imaging grading of clear cell renal cell carcinoma using a deep learning classifier.
Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clear cell renal cell carcinoma (ccRCC) is a malignant tumor, originating from the renal epithelium, and accounts for ~85% of RCC cases. The present study aimed to validate the efficacy of an MRI deep learning (DL) model to preoperatively predict the pathological grading of ccRCC. Therefore, a DL algorithm was constructed and trained using diffusion weighted imaging (DWI) and diffusion kurtosis imaging (DKI) sequence images. Subsequently, the apparent diffusion coefficient maps from DWI, as well as axial kurtosis (Ka), fractional anisotropy, radial kurtosis (Kr), mean kurtosis (MK) and mean diffusivity maps from DKI were calculated. The VGG-16 model was selected as the backbone architecture to validate the DL model. Based on the inclusion and exclusion criteria, a total of 79 patients with ccRCC, including 40 low- and 39 high-grade cases, were prospectively evaluated. Among the different image parameters, mean MK achieved the highest accuracy, with a precision of 81.48%, F1-score of 76.04%, recall of 74.08% and accuracy of 76.04%, followed by Kr, with values of 75.51, 75.36, 75.42 and 75.36%, respectively. Ka had precision, recall, F1-score and accuracy values of 81.39, 71.81, 68.31 and 71.81%, respectively. Overall, the results of the current study revealed that the established DL model, as a non-invasive algorithm based on MRI sequences, could accurately predict the pathological grading of ccRCC. Therefore, these findings highlighted the potential of this method to guide individualized treatment decisions for patients with ccRCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.